Dallah Healthcare Company (TADAWUL:4004)
Saudi Arabia
· Delayed Price · Currency is SAR 112.80
-3.50 (-3.01%)
Mar 9, 2026, 3:14 PM AST
Dallah Healthcare Company Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 11,415 | 14,607 | 16,782 | 13,320 | 6,759 | 4,126 | Upgrade
|
| Market Cap Growth | -21.85% | -12.96% | 25.99% | 97.07% | 63.82% | 23.72% | Upgrade
|
| Enterprise Value | 14,900 | 16,725 | 18,797 | 15,237 | 8,308 | 5,157 | Upgrade
|
| Last Close Price | 112.80 | 147.68 | 167.07 | 142.53 | 71.32 | 44.68 | Upgrade
|
| PE Ratio | 20.92 | 31.00 | 46.60 | 48.53 | 26.14 | 31.26 | Upgrade
|
| Forward PE | 17.22 | 28.71 | 41.05 | 42.65 | 32.23 | 29.40 | Upgrade
|
| PS Ratio | 3.03 | 4.56 | 5.70 | 5.35 | 3.21 | 3.13 | Upgrade
|
| PB Ratio | 2.53 | 3.90 | 4.83 | 5.97 | 3.23 | 2.06 | Upgrade
|
| P/TBV Ratio | 3.32 | 4.47 | 5.59 | 7.46 | 4.04 | 2.59 | Upgrade
|
| P/FCF Ratio | 113.29 | 46.43 | 50.66 | 49.44 | 27.48 | 76.51 | Upgrade
|
| P/OCF Ratio | 21.69 | 21.54 | 26.82 | 30.13 | 18.70 | 22.51 | Upgrade
|
| PEG Ratio | 0.96 | - | - | - | - | 1.68 | Upgrade
|
| EV/Sales Ratio | 3.96 | 5.22 | 6.39 | 6.12 | 3.95 | 3.91 | Upgrade
|
| EV/EBITDA Ratio | 17.52 | 24.52 | 30.80 | 29.63 | 18.12 | 21.82 | Upgrade
|
| EV/EBIT Ratio | 22.84 | 29.49 | 37.12 | 36.43 | 22.99 | 32.61 | Upgrade
|
| EV/FCF Ratio | 147.88 | 53.16 | 56.74 | 56.55 | 33.78 | 95.63 | Upgrade
|
| Debt / Equity Ratio | 0.74 | 0.54 | 0.57 | 0.89 | 0.90 | 0.76 | Upgrade
|
| Debt / EBITDA Ratio | 4.17 | 2.86 | 3.13 | 3.71 | 3.96 | 6.04 | Upgrade
|
| Debt / FCF Ratio | 33.30 | 6.43 | 5.96 | 7.34 | 7.68 | 28.36 | Upgrade
|
| Net Debt / Equity Ratio | 0.71 | 0.50 | 0.50 | 0.78 | 0.80 | 0.70 | Upgrade
|
| Net Debt / EBITDA Ratio | 4.16 | 2.72 | 2.85 | 3.38 | 3.67 | 5.92 | Upgrade
|
| Net Debt / FCF Ratio | 31.78 | 5.90 | 5.25 | 6.46 | 6.84 | 25.94 | Upgrade
|
| Asset Turnover | 0.49 | 0.50 | 0.53 | 0.52 | 0.48 | 0.37 | Upgrade
|
| Inventory Turnover | 7.81 | 8.61 | 8.02 | 6.87 | 7.07 | 6.48 | Upgrade
|
| Quick Ratio | 0.87 | 0.74 | 0.85 | 1.06 | 0.92 | 1.01 | Upgrade
|
| Current Ratio | 1.28 | 1.15 | 1.16 | 1.47 | 1.27 | 1.36 | Upgrade
|
| Return on Equity (ROE) | 12.94% | 13.44% | 13.51% | 13.65% | 13.40% | 7.65% | Upgrade
|
| Return on Assets (ROA) | 4.88% | 5.51% | 5.67% | 5.47% | 5.15% | 2.81% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.84% | 10.11% | 10.62% | 9.69% | 9.48% | 4.89% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.10% | 10.70% | 10.00% | 10.40% | 9.70% | 4.60% | Upgrade
|
| Earnings Yield | 4.69% | 3.23% | 2.15% | 2.06% | 3.83% | 3.20% | Upgrade
|
| FCF Yield | 0.88% | 2.15% | 1.97% | 2.02% | 3.64% | 1.31% | Upgrade
|
| Dividend Yield | 1.72% | 1.35% | 0.90% | 1.75% | 2.10% | 1.68% | Upgrade
|
| Payout Ratio | 37.43% | 41.38% | 40.69% | 65.58% | 62.84% | 75.67% | Upgrade
|
| Buyback Yield / Dilution | -1.77% | -0.20% | -8.16% | - | -4.56% | 1.72% | Upgrade
|
| Total Shareholder Return | -0.05% | 1.16% | -7.26% | 1.75% | -2.45% | 3.40% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.